HMOs approval in China infant formula is a game changer

HMOs approval in China infant formula is a game changer

January 29, 2024

In October 2023, International Flavours and Fragrance (IFF), dsf-firmenich and local milk player Mengniu received approval for use of their HMO component in infant formula in China. Human milk oligosaccharides (HMOs), the third most abundant solid ingredient in breast milk, offer significant benefits for infant development and health by modulating the immune system and supporting the growth of beneficial gut bacteria.

Chinese regulations now permit the use of HMOs in various formula types, including infant milk formula, follow-up milk, infant formula for special medical purposes, and formulated milk powder for children. This development is especially noteworthy as HMOs, traditionally produced through a fermentation process involving genetically modified organisms, are gaining popularity among Chinese parents. Mintel research shows that 45% of Chinese parents who are feeding their babies aged 0-3 with infant milk formula are attracted to formula with more HMOs.

New infant formula product development in China has seen a decline over the years, with Mintel GNPD indicating a drop from 29% between October 2019 to September 2020 to 14% between October 2022 to September 2023. HMOs have the potential to revitalize the category by bringing infant formula closer to the nutritional composition of breast milk.

HMOs bridge the gap between bottle and breastfeeding

Despite the acknowledged benefits of breastfeeding, significant barriers exist for mothers. For example, at least 10 cities in China are reported not to have nursing rooms in public spaces, making it difficult for working women who want to continue breastfeeding.

HMOs incorporated into infant formula provide a viable alternative to bread feeding, making essential nutrients more accessible to infants. Over half of Chinese parents with children aged 0-3 believe that formula products with ingredients similar to breast milk can replace breastfeeding, according to Mintel research.

Furthermore, the gut-immune axis can strengthen the appeal of HMOs in preventing immunity and digestion issues, which are among the top health issues cited among parents of children aged 4-12 in 2022.

Educating and engaging parents

More than a third of Chinese consumers who have fed babies aged 0-3 with infant milk formula have heard of HMOs, but they are unaware of their function. The Enfamil Brand links its HMO ingredient directly to immune support on the front of pack to help consumers understand its health benefits. In addition, the brand further explains its proprietary blend to help support immune health on its website.

Enfamil Neuro Pro (Canada); Mintel GNPD

The production of HMOs on an industrial scale requires the use of precision fermentation. While the ingredients are not genetically engineered, there may be traces of genetically engineered material from the microbes used. Besides highlighting functional benefits, brands need to educate consumers about the safety and benefits of using science to improve the nutritional profile of milk formulas.

For example, Nutifood Grow Plus+ combines research from Nutifood Nutrition Research Institute in Sweden and Nutifood’s nutritionists’ knowledge of Vietnamese children’s specifications for healthy growth.

Nutifood Grow Plus+ (Vietnam); Mintel GNPD

Many parents seek enhanced nutritional content, such as DHA/ARA, prebiotics, and probiotics, in infant milk formula. However, Mintel research shows that 52% of Chinese parents find the nutrition labeling on infant milk formulas confusing. Brands have the opportunity to communicate tangible health advantages associated with specific nutritional components for children.

What we think

The approval of HMOs use in China marks a pivotal moment for the infant formula sector. Bridging the nutritional gap between formula and breast milk, HMOs offer a practical solution for mothers facing challenges in breastfeeding. As brands continue to educate consumers about the safety and benefits of HMOs, the infant formula market may experience a resurgence, ensuring the optimal health of China’s youngest generation.

Mintel’s food and drink market research keeps you on top of the latest consumer, product, ingredient trends and more. For further insights on baby food and formula, please visit the Mintel Store.

Jolene Ng
Jolene Ng

Principal Food & Drink Analyst, APAC

 

Based in Singapore, Jolene has over 12 years of experience in the consumer goods industry. In her current role as Principal Food and Drink Analyst, Jolene explores global consumer trends, product innovation and market competition, and people management while also delivering presentations on trends and innovation in the food industry trade shows and forums. Jolene also specialises in a range of categories including salty snacks and baby food and milk.

More from Mintel
  • Mintel Store
    Mintel Store
    Get smart fast with our exclusive market research reports, delivering the latest data, innovation, trends and strategic recommendations....
    View reports
  • Mintel Leap
    Mintel Leap is a revolutionary new AI-powered platform that will transform your research process....
    Book a demo
Subscribe to Mintel Spotlight
Related articles
February 29, 2024
In recent years, chocolate consumption in India has seen significant growth, with a sizable portion of consumers embracing this indulgent treat. Mintel research shows that six in 10 Indians have…
February 28, 2024
Consumers’ approach to healthy eating is changing. A post-pandemic focus on health and preventive nutrition, ongoing economic challenges, and more research into the health risks of ultra-processed foods are impacting…
February 26, 2024
With a global cheese market that is still growing, cheese has long been a dietary staple for communities around the world. Though its exact origins are unknown, cheese has a…
Featured Downloads